{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:41:48Z","timestamp":1783690908226,"version":"3.55.0"},"reference-count":20,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,4,23]],"date-time":"2002-04-23T00:00:00Z","timestamp":1019520000000},"content-version":"vor","delay-in-days":53,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Pathol"],"published-print":{"date-parts":[[2002,3]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Anthracycline antitumor antibiotics are the most commonly used chemotherapeutic agents. One of these is doxorubicin. Liposomal doxorubicin was developed as a drug delivery system in order to deliver the active drug intracellularly while decreasing the systemic toxicity, particularly hematological and cardiac toxicity.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> The clinical and histologic findings of the cutaneous eruptions of associated with liposomal doxorubicin are reviewed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The eruptions occurred in three women with metastatic ovarian carcinoma who were treated with liposomal doxorubicin. These three patients developed erythematous macular\/papular to plaque cutaneous lesions, and in one patient a vesicular component. The eruptions involved the trunk and extremities approximately 3\u20134\u2003weeks after completions of therapy. None of the patients had any documented infections, and none of the patients had symptoms other than pruritus. The eruptions cleared over a period of weeks to months. Histologic features included an interface dermatitis with numerous apoptotic\/dyskeratotic cells within the epidermis, with involvement the intra\u2010epidermal sweat ducts and the infundibulum of hair follicles.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> We believe that these eruptions represented a chemotherapy induced host\u2010vs.\u2010altered host reaction.<\/jats:p>","DOI":"10.1034\/j.1600-0560.2002.290304.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T13:54:58Z","timestamp":1047390898000},"page":"148-153","source":"Crossref","is-referenced-by-count":24,"title":["Host\u2010vs.\u2010altered\u2010host eruptions in patients on liposomal doxorubicin"],"prefix":"10.1111","volume":"29","author":[{"given":"Henry","family":"Skelton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Linstrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,4,23]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199447020-00002"},{"key":"e_1_2_6_3_2","first-page":"1","article-title":"Anthracyclines in the treatment of cancer. An overview","volume":"54","author":"Hortobigyi GN","year":"1997","journal-title":"Drugs"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(97)90020-5"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199615060-00005"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197509)36:3<946::AID-CNCR2820360316>3.0.CO;2-5"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-85-3-294"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-96-2-133"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-91-5-710"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JCO.1996.14.2.332","article-title":"Anthracycline cardiac toxicity by dexazoxane breakthough of a barrier \u2212 sharpens antitumor profile and therapeutic index","volume":"14","author":"Helleman K","year":"1996","journal-title":"J Clin Oncol"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199346040-00004"},{"key":"e_1_2_6_12_2","first-page":"431","article-title":"Liposomal anthracyclines","volume":"8","author":"Gabizon AA","year":"1994","journal-title":"Hematol Oncol Clin N Am"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199700544-00005"},{"key":"e_1_2_6_14_2","first-page":"22SS","article-title":"Clinical efficacy and prospects for use of pegylated liposomal soxorubicin in the treatment of ovarian and breast cancers","volume":"54","author":"Maggia F","year":"1997","journal-title":"Drugs"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199700544-00007"},{"key":"e_1_2_6_16_2","first-page":"184S","article-title":"Comparison of pharmacokinetics (PK) of free and liposome encapsulated soxurubicin in advanced cancer patients","volume":"18","author":"Schller J","year":"1995","journal-title":"Onkologn"},{"key":"e_1_2_6_17_2","first-page":"1484","article-title":"Antiboy\u2010targeted delivery of doxirubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice","volume":"53","author":"Ahamd I","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199753030-00011"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1200\/JCO.1997.15.3.987","article-title":"Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumour activity and toxicity modification by liposomal encapsulation","volume":"15","author":"Maggia FM","year":"1997","journal-title":"J Clin Oncol"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001043220101"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.9.2451.2451"}],"container-title":["Journal of Cutaneous Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0560.2002.290304.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0560.2002.290304.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0560.2002.290304.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T06:33:22Z","timestamp":1697524402000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0560.2002.290304.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["10.1034\/j.1600-0560.2002.290304.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0560.2002.290304.x","archive":["Portico"],"relation":{},"ISSN":["0303-6987","1600-0560"],"issn-type":[{"value":"0303-6987","type":"print"},{"value":"1600-0560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}